-
1
-
-
0025330168
-
The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis
-
Adler DJ, Korelitz BI. The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis. Am. J. Gastroenterol. 1990 85 : 717 22.
-
(1990)
Am. J. Gastroenterol.
, vol.85
, pp. 717-722
-
-
Adler, D.J.1
Korelitz, B.I.2
-
2
-
-
84921430591
-
-
Cochrane Database Syst. Rev.
-
Sandborn W, Sutherland L, Pearson D, May G, Modigliani R, Prantera C. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease. Cochrane Database Syst. Rev. 2000 CD000545.
-
(2000)
Azathioprine or 6-mercaptopurine for Inducing Remission of Crohn's Disease
-
-
Sandborn, W.1
Sutherland, L.2
Pearson, D.3
May, G.4
Modigliani, R.5
Prantera, C.6
-
3
-
-
33644500497
-
Novel pathophysiological concepts of inflammatory bowel disease
-
Hibi T, Ogata H. Novel pathophysiological concepts of inflammatory bowel disease. J. Gastroenterol. 2006 41 : 10 16.
-
(2006)
J. Gastroenterol.
, vol.41
, pp. 10-16
-
-
Hibi, T.1
Ogata, H.2
-
4
-
-
4544239107
-
Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease
-
Gearry RB, Barclay ML, Burt MJ, Collett JA, Chapman BA. Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease. Pharmacoepidemiol. Drug Saf. 2004 13 : 563 7.
-
(2004)
Pharmacoepidemiol. Drug Saf.
, vol.13
, pp. 563-567
-
-
Gearry, R.B.1
Barclay, M.L.2
Burt, M.J.3
Collett, J.A.4
Chapman, B.A.5
-
5
-
-
33745513801
-
Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease
-
Derijks LJ, Gilissen LP, Engels LG et al. Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease. Ther. Drug Monit. 2006 28 : 45 50.
-
(2006)
Ther. Drug Monit.
, vol.28
, pp. 45-50
-
-
Derijks, L.J.1
Gilissen, L.P.2
Engels, L.G.3
-
6
-
-
37249032702
-
IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - Relation to TPMT activity and metabolite concentrations
-
Haglund S, Taipalensuu J, Peterson C, Almer S. IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations. Br. J. Clin. Pharmacol. 2007 65 : 69 77.
-
(2007)
Br. J. Clin. Pharmacol.
, vol.65
, pp. 69-77
-
-
Haglund, S.1
Taipalensuu, J.2
Peterson, C.3
Almer, S.4
-
7
-
-
33646011261
-
Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: A meta-analysis
-
Osterman MT, Kundu R, Lichtenstein GR, Lewis JD. Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis. Gastroenterology 2006 130 : 1047 53.
-
(2006)
Gastroenterology
, vol.130
, pp. 1047-1053
-
-
Osterman, M.T.1
Kundu, R.2
Lichtenstein, G.R.3
Lewis, J.D.4
-
8
-
-
0242464926
-
CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes
-
Tiede I, Fritz G, Strand S et al. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J. Clin. Invest. 2003 111 : 1133 45.
-
(2003)
J. Clin. Invest.
, vol.111
, pp. 1133-1145
-
-
Tiede, I.1
Fritz, G.2
Strand, S.3
-
9
-
-
0034093057
-
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
-
Colombel JF, Ferrari N, Debuysere H et al. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology 2000 118 : 1025 30.
-
(2000)
Gastroenterology
, vol.118
, pp. 1025-1030
-
-
Colombel, J.F.1
Ferrari, N.2
Debuysere, H.3
-
10
-
-
0042830383
-
Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease
-
Gearry RB, Barclay ML, Burt MJ et al. Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease. Aliment. Pharmacol. Ther. 2003 18 : 395 400.
-
(2003)
Aliment. Pharmacol. Ther.
, vol.18
, pp. 395-400
-
-
Gearry, R.B.1
Barclay, M.L.2
Burt, M.J.3
-
11
-
-
0035037703
-
Rational dosing of azathioprine and 6-mercaptopurine
-
Sandborn WJ. Rational dosing of azathioprine and 6-mercaptopurine. Gut 2001 48 : 591 2.
-
(2001)
Gut
, vol.48
, pp. 591-592
-
-
Sandborn, W.J.1
-
12
-
-
0141521863
-
Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis
-
Hibi T, Naganuma M, Kitahora T, Kinjyo F, Shimoyama T. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis. J. Gastroenterol. 2003 38 : 740 6.
-
(2003)
J. Gastroenterol.
, vol.38
, pp. 740-746
-
-
Hibi, T.1
Naganuma, M.2
Kitahora, T.3
Kinjyo, F.4
Shimoyama, T.5
-
13
-
-
0024587677
-
Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial
-
Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989 298 : 82 6.
-
(1989)
BMJ
, vol.298
, pp. 82-86
-
-
Rachmilewitz, D.1
-
14
-
-
0017227303
-
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study
-
Jr.
-
Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976 70 : 439 44.
-
(1976)
Gastroenterology
, vol.70
, pp. 439-444
-
-
Best, W.R.1
Becktel, J.M.2
Singleton, J.W.3
Kern, F.4
-
15
-
-
0035811191
-
Improved methods for determining the concentration of 6-thioguanine nucleotides and 6-methylmercaptopurine nucleotides in blood
-
Pike MG, Franklin CL, Mays DC, Lipsky JJ, Lowry PW, Sandborn WJ. Improved methods for determining the concentration of 6-thioguanine nucleotides and 6-methylmercaptopurine nucleotides in blood. J. Chromatogr. B Biomed Sci. Appl. 2001 757 : 1 9.
-
(2001)
J. Chromatogr. B Biomed Sci. Appl.
, vol.757
, pp. 1-9
-
-
Pike, M.G.1
Franklin, C.L.2
Mays, D.C.3
Lipsky, J.J.4
Lowry, P.W.5
Sandborn, W.J.6
-
16
-
-
0030934850
-
Molecular diagnosis of thiopurine S-methyltransferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance
-
Yates CR, Krynetski EY, Loennechen T et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann. Intern. Med. 1997 126 : 608 14.
-
(1997)
Ann. Intern. Med.
, vol.126
, pp. 608-614
-
-
Yates, C.R.1
Krynetski, E.Y.2
Loennechen, T.3
-
17
-
-
0037256180
-
Introduction and overview: Recent advances in the immunotherapy of inflammatory bowel disease
-
Hibi T, Inoue N, Ogata H, Naganuma M. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease. J. Gastroenterol. 2003 38 (Suppl. 15 36 42.
-
(2003)
J. Gastroenterol.
, vol.3815
, pp. 36-42
-
-
Hibi, T.1
Inoue, N.2
Ogata, H.3
Naganuma, M.4
-
18
-
-
4344587708
-
Therapeutic drug monitoring in patients with inflammatory bowel disease and established azathioprine therapy
-
Gilissen LP, Derijks LJ, Bos LP, Bus PJ, Hooymans PM, Engels LG. Therapeutic drug monitoring in patients with inflammatory bowel disease and established azathioprine therapy. Clin. Drug Invest. 2004 24 : 479 86.
-
(2004)
Clin. Drug Invest.
, vol.24
, pp. 479-486
-
-
Gilissen, L.P.1
Derijks, L.J.2
Bos, L.P.3
Bus, P.J.4
Hooymans, P.M.5
Engels, L.G.6
-
19
-
-
4544294487
-
The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease
-
Goldenberg BA, Rawsthorne P, Bernstein CN. The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease. Am. J. Gastroenterol. 2004 99 : 1744 8.
-
(2004)
Am. J. Gastroenterol.
, vol.99
, pp. 1744-1748
-
-
Goldenberg, B.A.1
Rawsthorne, P.2
Bernstein, C.N.3
-
20
-
-
0035037706
-
Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease
-
Cuffari C, Hunt S, Bayless T. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease. Gut 2001 48 : 642 6.
-
(2001)
Gut
, vol.48
, pp. 642-646
-
-
Cuffari, C.1
Hunt, S.2
Bayless, T.3
-
21
-
-
3242732900
-
Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease
-
Wright S, Sanders DS, Lobo AJ, Lennard L. Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease. Gut 2004 53 : 1123 8.
-
(2004)
Gut
, vol.53
, pp. 1123-1128
-
-
Wright, S.1
Sanders, D.S.2
Lobo, A.J.3
Lennard, L.4
-
22
-
-
0034067784
-
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
-
Dubinsky MC, Lamothe S, Yang HY et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000 118 : 705 13.
-
(2000)
Gastroenterology
, vol.118
, pp. 705-713
-
-
Dubinsky, M.C.1
Lamothe, S.2
Yang, H.Y.3
-
23
-
-
0035186469
-
6-mercaptopurine metabolite levels in children with inflammatory bowel disease
-
Gupta P, Gokhale R, Kirschner BS. 6-mercaptopurine metabolite levels in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 2001 33 : 450 4.
-
(2001)
J. Pediatr. Gastroenterol. Nutr.
, vol.33
, pp. 450-454
-
-
Gupta, P.1
Gokhale, R.2
Kirschner, B.S.3
-
24
-
-
27744461917
-
Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease
-
Gearry RB, Barclay ML. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease. J. Gastroenterol. Hepatol. 2005 20 : 1149 57.
-
(2005)
J. Gastroenterol. Hepatol.
, vol.20
, pp. 1149-1157
-
-
Gearry, R.B.1
Barclay, M.L.2
-
25
-
-
2542596944
-
Frequency distribution of thiopurine S-methyltransferase activity in red blood cells of a healthy Japanese population
-
Kubota T, Nishida A, Takeuchi K et al. Frequency distribution of thiopurine S-methyltransferase activity in red blood cells of a healthy Japanese population. Ther. Drug Monit. 2004 26 : 319 21.
-
(2004)
Ther. Drug Monit.
, vol.26
, pp. 319-321
-
-
Kubota, T.1
Nishida, A.2
Takeuchi, K.3
-
27
-
-
34247094129
-
Three novel single nucleotide polymorphisms of the human thiopurine S-methyltransferase gene in Japanese individuals
-
Sasaki T, Goto E, Konno Y, Hiratsuka M, Mizugaki M. Three novel single nucleotide polymorphisms of the human thiopurine S-methyltransferase gene in Japanese individuals. Drug Metab. Pharmacokinet. 2006 21 : 332 6.
-
(2006)
Drug Metab. Pharmacokinet.
, vol.21
, pp. 332-336
-
-
Sasaki, T.1
Goto, E.2
Konno, Y.3
Hiratsuka, M.4
Mizugaki, M.5
|